Gefitinib is a targeted cancer therapy used primarily in the treatment of non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), designed to ...
Gefitinib is a targeted cancer therapy used primarily in the treatment of non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), designed to ...